bpc-157 clinical trials human evidence safety review regulatory status Frontiers bpc-157 human clinical trial evidence – bpc-157 human clinical trial evidence

Patients whose labs improved but fatigue, sleep disruption, or focus issues did not meaningfully change

It is a synthetic peptide derived from a naturally occurring protein found in gastric juice

Adjacent human efficacy in non-growth indications Borasio et al

Grubb prescribes peptide therapy to treat various musculoskeletal conditions, including: Disc herniation (herniated intervertebral discs) Back pain Neck pain Cervical spinal stenosis (narrowing of the spinal canal in the neck) Lumbar spinal stenosis (narrowing of the spinal canal in the lower back) Radiculopathy (nerve compression/irritation) Peptide therapy is quick, pain-free, and significantly less risky than minimally invasive and open spine surgery

It plays a critical role in energy metabolism, DNA repair, and cellular signaling

This allows time for potential recurrence to manifest and be detected